Ad
Monday, 4 May 2020
BioMerieux COVID testing product gets U.S. emergency use authorization
Biomérieux, a French healthcare company specialising in diagnostics, said on Monday it had won more positive feedback from the U.S. Food & Drug Administration (FDA) regulator for its product aimed at helping test for the coronavirus.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment